tiprankstipranks
Aequus Pharmaceuticals Inc (TSE:AQS)
TSXV:AQS
Holding TSE:AQS?
Track your performance easily

Aequus Pharmaceuticals (AQS) Financial Statements

14 Followers

Aequus Pharmaceuticals Financial Overview

Aequus Pharmaceuticals's market cap is currently ―. The company's EPS TTM is C$-0.02; its P/E ratio is -0.74; Aequus Pharmaceuticals is scheduled to report earnings on November 27, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total RevenueC$ 148.32KC$ 161.41KC$ 52.55KC$ 50.88KC$ 13.36K
Gross ProfitC$ 75.44KC$ 74.85KC$ 34.96KC$ 35.57KC$ 2.90K
EBITC$ -614.73KC$ -683.03KC$ -609.75KC$ -668.23KC$ -767.87K
EBITDAC$ -581.65KC$ -649.95KC$ -576.67KC$ -634.31KC$ -733.12K
Net Income Common StockholdersC$ -614.73KC$ -683.03KC$ -662.09KC$ -715.87KC$ -803.65K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 70.26KC$ 88.93KC$ 286.89KC$ 215.05KC$ 156.87K
Total AssetsC$ 858.02KC$ 1.01MC$ 1.09MC$ 1.09MC$ 1.86M
Total DebtC$ 612.23KC$ 639.93KC$ 667.16KC$ 693.78KC$ 717.49K
Net DebtC$ 541.98KC$ 551.00KC$ 380.26KC$ 478.73KC$ 560.62K
Total LiabilitiesC$ 7.08MC$ 6.62MC$ 6.04MC$ 5.38MC$ 4.76M
Stockholders EquityC$ -6.22MC$ -5.61MC$ -4.95MC$ -4.29MC$ -3.59M
Cash Flow-
Free Cash FlowC$ -348.70KC$ -706.10KC$ -521.70KC$ -902.11KC$ -649.73K
Operating Cash FlowC$ -348.70KC$ -706.10KC$ -521.70KC$ -902.11KC$ -649.73K
Investing Cash Flow-----
Financing Cash FlowC$ 330.02KC$ 508.14KC$ 593.55KC$ 960.29KC$ 731.36K
Currency in CAD

Aequus Pharmaceuticals Earnings and Revenue History

Aequus Pharmaceuticals Debt to Assets

Aequus Pharmaceuticals Cash Flow

Aequus Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis